Isogenic human pluripotent stem cell disease models reveal ABRA deficiency underlies cTnT mutation-induced familial dilated cardiomyopathy

References

[1] Arai A, Spencer JA, Olson EN (2002) STARS, a striated muscle activator of Rho signaling and serum response factor-dependent transcription. J Biol Chem 277:24453–24459

[2] Furuya Y, Denda M, Sakane K, Ogusu T, Takahashi S, Magari M, Kanayama N, Morishita R, Tokumitsu H (2016) Identification of striated muscle activator of Rho signaling (STARS) as a novel calmodulin target by a newly developed genome-wide screen. Cell Calcium 60:32–40

[3] Hershberger RE, Hedges DJ, Morales A (2013) Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol 10:531–547

[4] Jefferies JL, Towbin JA (2010) Dilated cardiomyopathy. The Lancet 375:752–762

[5] Juan F, Wei D, Xiongzhi Q, Ran D, Chunmei M, Lan H, Chuan Q, Lianfeng Z (2008) The changes of the cardiac structure and function in cTnTR141W transgenic mice. Int J Cardiol 128:83–90

[6] Kamisago M, Sharma SD, DePalma SR, Solomon S, Sharma P, McDonough B,Smoot L, Mullen MP, Woolf PK, Wigle ED (2000) Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 343:1688–1696

[7] Kathiresan S, Srivastava D (2012) Genetics of human cardiovascular disease. Cell 148:1242–1257

[8] Kehat I, Molkentin JD (2010) Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation 122:2727–2735

[9] Kuwahara K, Teg Pipes GC, McAnally J, Richardson JA, Hill JA, Bassel-Duby R, Olson EN (2007) Modulation of adverse cardiac remodeling by STARS, a mediator of MEF2 signaling and SRF activity. J Clin Investig 117:1324–1334

[10] Lamon S, Wallace MA, Leger B, Russell AP (2009) Regulation of STARS and its downstream targets suggest a novel pathway involved in human skeletal muscle hypertrophy and atrophy. J Physiol 587:1795–1803

[11] McNally EM, Mestroni L (2017) Dilated cardiomyopathy: genetic determinants and mechanisms. Circ Res 121:731–748

[12] Morimoto S, Lu QW, Harada K, Takahashi-Yanaga F, Minakami R, Ohta M,Sasaguri T, Ohtsuki I (2002) Ca(2+)-desensitizing effect of a deletion mutation Delta K210 in cardiac troponin T that causes familial dilated cardiomyopathy. Proc Natl Acad Sci USA 99:913–918

[13] Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M (2003) Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107:2227–2232

[14] Wallace MA, Lamon S, Russell AP (2012) The regulation and function of the striated muscle activator of rho signaling (STARS) protein. Front Physiol 3:469

[15] Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O’Donoghue A, Spirito P, Matsumori A, Moravec CS, Seidman JG (1995) Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 332:1058–1064

RIGHTS & PERMISSIONS

The Author(s)